Sanofi

Sanofi – Paul Hudson comments on Q3 2024 results

Sanofi – Paul Hudson commente les résultats du troisième trimestre 2024

Sanofi – Responsible AI @ Sanofi – Bias & Fairness

Sanofi – Nos leaders à VivaTech 2024

Sanofi – Our Leaders at VivaTech 2024

Sanofi - Responsible AI @ Sanofi – Accountability

Sanofi – Responsible AI @ Sanofi – Environnemental Impact & Opportunities

Sanofi – Paul Hudson comments on Q1 2024 results

Sanofi – Paul Hudson comments on 2023 results

Sanofi – R&D Day

Sanofi Careers – The Ambition of Sanofi Manufacturing & Supply (longer version)

Sanofi – Connecting the Dots: Leveraging Technology to Design More Diverse Clinical Trials

Sanofi – Ensemble, nous menons le relais de la science

Sanofi – Meet Chaima - a Sanofi NextGen scholar from France.

Sanofi – Impulsion 2024 : Édition #2 : Parcours de santé

Sanofi – Maladie du sommeil : Ne laisser personne de côté

Sanofi – Our oncology ambition

Sanofi –

Sanofi – Our Insulin Campus

Sanofi – Meet Audrey Lhomme, Amber Doss, Gabriela Pacheco and Cristina Zamora.

Sanofi – The Importance of Early Detection in Rare Disease

Sanofi – A celles et ceux qui nous poussent à ne jamais lâcher : Yul

Sanofi – Dermatology Expert vs AI: Skin Tones

An overview of Atrial Fibrillation

Sanofi – Vivre notre vocation

Sanofi – Edna, Nasal Polyps

Sanofi – Lancement de Foundation S - The Sanofi Collective

Sanofi – Best of Team Sanofi

Sanofi – The value of EBRG at Sanofi

Sanofi – Créer des Vaccins

Sanofi – 200 jours avant les Jeux Paralympiques

Sanofi – A Parent’s Perspective: Dina and Winnie’s RSV Story